Recently, the Centers for Medicare and Medicaid Services (CMS) issued its much anticipated final Medicare Advantage and Medicare Part D Drug Pricing Rule (CMS-4180-F). At this time, CMS has decided not to include much needed reforms of Direct and Indirect Remuneration (DIR) fee practices. Currently there is a NACDS RxIMPACT campaign designed to assist independent pharmacies in this continued fight. They are calling on YOU to write your legislators and ask members of the US Senate to take part in a congressional sign-on letter. We encourage you to participate today!
for more details and find out how you can take action today!